IE920055A1 - Improvements in and relating to hormones - Google Patents

Improvements in and relating to hormones

Info

Publication number
IE920055A1
IE920055A1 IE005592A IE920055A IE920055A1 IE 920055 A1 IE920055 A1 IE 920055A1 IE 005592 A IE005592 A IE 005592A IE 920055 A IE920055 A IE 920055A IE 920055 A1 IE920055 A1 IE 920055A1
Authority
IE
Ireland
Prior art keywords
analogue
gnrh
piscine
amino acid
fish
Prior art date
Application number
IE005592A
Other languages
English (en)
Original Assignee
Proteus Molecular Sign Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Molecular Sign Ltd filed Critical Proteus Molecular Sign Ltd
Publication of IE920055A1 publication Critical patent/IE920055A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Circuits Of Receivers In General (AREA)
IE005592A 1991-01-09 1992-01-08 Improvements in and relating to hormones IE920055A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919100468A GB9100468D0 (en) 1991-01-09 1991-01-09 Improvements in and relating to hormones

Publications (1)

Publication Number Publication Date
IE920055A1 true IE920055A1 (en) 1992-07-15

Family

ID=10688207

Family Applications (1)

Application Number Title Priority Date Filing Date
IE005592A IE920055A1 (en) 1991-01-09 1992-01-08 Improvements in and relating to hormones

Country Status (17)

Country Link
EP (1) EP0566611A1 (fr)
JP (1) JPH06504537A (fr)
KR (1) KR930703444A (fr)
CN (1) CN1063109A (fr)
AU (1) AU652611B2 (fr)
CA (1) CA2100057A1 (fr)
DK (1) DK80993D0 (fr)
FI (1) FI933138L (fr)
GB (2) GB9100468D0 (fr)
HU (1) HUT66829A (fr)
IE (1) IE920055A1 (fr)
IS (1) IS3802A (fr)
NO (1) NO932491D0 (fr)
NZ (1) NZ241240A (fr)
PT (1) PT99991A (fr)
WO (1) WO1992012247A1 (fr)
ZW (1) ZW392A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950702839A (ko) * 1992-08-27 1995-08-23 스티븐 딕 레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues)
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US5760000A (en) * 1994-05-13 1998-06-02 University Technologies International,Inc. Inhibition of liver cancer by the use of GnRH and GnRH analogs
AU1765300A (en) * 1998-12-22 2000-07-12 Dalhousie University Compositions and methods for reducing or preventing fertilization in fish and birds
GB0226179D0 (en) 2002-11-09 2002-12-18 Millar Robert P Vaccine
NO20075894L (no) * 2007-11-15 2009-05-18 Thia Medica As Redusert kjonnsmodning i fisk
JP6909160B2 (ja) * 2015-11-27 2021-07-28 日本水産株式会社 細胞膜透過性ペプチド及び細胞膜透過性ペプチドを用いた魚類飼料

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
EP0592512A1 (fr) * 1991-07-01 1994-04-20 University Technologies International Inc. (Uti) Analogues non desensibilisants de gonadoliberine et d'autres ligands biologiquement actifs

Also Published As

Publication number Publication date
IS3802A (is) 1992-07-10
HU9301979D0 (en) 1993-11-29
NO932491L (no) 1993-07-08
HUT66829A (en) 1995-01-30
AU652611B2 (en) 1994-09-01
ZW392A1 (en) 1992-07-22
JPH06504537A (ja) 1994-05-26
PT99991A (pt) 1993-01-29
GB2267496B (en) 1994-09-07
GB9100468D0 (en) 1991-02-20
KR930703444A (ko) 1993-11-30
FI933138A0 (fi) 1993-07-08
DK80993A (da) 1993-07-06
WO1992012247A1 (fr) 1992-07-23
NO932491D0 (no) 1993-07-08
GB9314141D0 (en) 1993-09-22
NZ241240A (en) 1992-11-25
AU1161792A (en) 1992-08-17
CA2100057A1 (fr) 1992-07-10
CN1063109A (zh) 1992-07-29
EP0566611A1 (fr) 1993-10-27
FI933138A7 (fi) 1993-07-08
GB2267496A (en) 1993-12-08
DK80993D0 (da) 1993-07-06
FI933138L (fi) 1993-07-08

Similar Documents

Publication Publication Date Title
US4493795A (en) Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
CA1329766C (fr) Epitopes d'une proteine de la capside nucleique du virus de l'hepatite b stimulant les lymphocytes t
Yi-An et al. Chemically unambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system
JP4619120B2 (ja) Ｔヘルパーエピトープおよびｂ細胞エピトープを含む新規な免疫原性リポペプチド
TWI225069B (en) Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
US4859765A (en) Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
EP0652896A1 (fr) Composes peptidiques
JPS58201754A (ja) 合成ｓｔ毒素、その製造方法およびそのワクチン接種剤としての用途
WO1991008220A1 (fr) Procede de synthese regulee par etapes d'especes chimiques, notamment de peptides, de produits couples obtenus selon le procede, et emploi de ces produits couples, par exemple en tant que vaccins
JPH08504090A (ja) 抗−ネコ免疫不全ウイルス（ｆｉｖ）ワクチン
AU622858B2 (en) Biologically active molecules
AU652611B2 (en) Analogs of piscine LHRH
RU2034457C1 (ru) Способ повышения продуктивности сельскохозяйственных животных и препарат для его осуществления
EP0450715B1 (fr) Composés immunogènes, procédé en vue de leur synthèse et leur utilisation dans des vaccins contre la malaria
JP2509312B2 (ja) ペプチド構造体、それらを含む免疫原及び妊性の調節へのそれらの使用
US4782136A (en) Synthetic peptide compounds producing anitbodies binding to human LDH-C.sub.
EP0079934B1 (fr) Composes de peptides lineaires antigeniques
WO1989000166A2 (fr) Peptides relatifs a l'hormone de croissance
US4377516A (en) Antigenic linear peptide compounds
US4578219A (en) Antigenic peptide compound
WO1999066950A1 (fr) Immunogenes synthetiques a base de somatostatine servant a stimuler la croissance chez des animaux d'elevage
WO1994004565A2 (fr) Vaccin vnpi
AU623148B2 (en) Probursin
DK173981B1 (da) Farmaceutisk antigenetisk formulering
CS272790A2 (en) Peptides with biological effect

Legal Events

Date Code Title Description
FC9A Application refused sect. 31(1)